223 related articles for article (PubMed ID: 24265214)
1. A nanoscaffold impregnated with human wharton's jelly stem cells or its secretions improves healing of wounds.
Tam K; Cheyyatraviendran S; Venugopal J; Biswas A; Choolani M; Ramakrishna S; Bongso A; Fong CY
J Cell Biochem; 2014 Apr; 115(4):794-803. PubMed ID: 24265214
[TBL] [Abstract][Full Text] [Related]
2. Human Wharton's jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds.
Fong CY; Tam K; Cheyyatraivendran S; Gan SU; Gauthaman K; Armugam A; Jeyaseelan K; Choolani M; Biswas A; Bongso A
J Cell Biochem; 2014 Feb; 115(2):290-302. PubMed ID: 24038311
[TBL] [Abstract][Full Text] [Related]
3. Histological, immunohistochemical, and genomic evaluation of excisional and diabetic wounds treated with human Wharton's jelly stem cells with and without a nanocarrier.
Raj V; Claudine S; Subramanian A; Tam K; Biswas A; Bongso A; Fong CY
J Cell Biochem; 2019 Jul; 120(7):11222-11240. PubMed ID: 30706534
[TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo.
Fong CY; Gauthaman K; Cheyyatraivendran S; Lin HD; Biswas A; Bongso A
J Cell Biochem; 2012 Feb; 113(2):658-68. PubMed ID: 21976004
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of growth of Asian keloid cells with human umbilical cord Wharton's jelly stem cell-conditioned medium.
Arjunan S; Gan SU; Choolani M; Raj V; Lim J; Biswas A; Bongso A; Fong CY
Stem Cell Res Ther; 2020 Feb; 11(1):78. PubMed ID: 32085797
[TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells.
Subramanian A; Shu-Uin G; Kae-Siang N; Gauthaman K; Biswas A; Choolani M; Bongso A; Chui-Yee F
J Cell Biochem; 2012 Jun; 113(6):1886-95. PubMed ID: 22234854
[TBL] [Abstract][Full Text] [Related]
7. Human Wharton's jelly stem cell conditioned medium and cell-free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice.
Gauthaman K; Fong CY; Arularasu S; Subramanian A; Biswas A; Choolani M; Bongso A
J Cell Biochem; 2013 Feb; 114(2):366-77. PubMed ID: 22930595
[TBL] [Abstract][Full Text] [Related]
8. Osteogenic differentiation of human Wharton's jelly stem cells on nanofibrous substrates in vitro.
Gauthaman K; Venugopal JR; Yee FC; Biswas A; Ramakrishna S; Bongso A
Tissue Eng Part A; 2011 Jan; 17(1-2):71-81. PubMed ID: 20673136
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic human umbilical cord Wharton's jelly stem cells increase several-fold the expansion of human cord blood CD34+ cells both in vitro and in vivo.
Lin HD; Fong CY; Biswas A; Bongso A
Stem Cell Res Ther; 2020 Dec; 11(1):527. PubMed ID: 33298170
[TBL] [Abstract][Full Text] [Related]
10. Human Wharton's Jelly Mesenchymal Stem Cells Show Unique Gene Expression Compared with Bone Marrow Mesenchymal Stem Cells Using Single-Cell RNA-Sequencing.
Barrett AN; Fong CY; Subramanian A; Liu W; Feng Y; Choolani M; Biswas A; Rajapakse JC; Bongso A
Stem Cells Dev; 2019 Feb; 28(3):196-211. PubMed ID: 30484393
[TBL] [Abstract][Full Text] [Related]
11. Human Umbilical Cord Wharton's Jelly Stem Cell Conditioned Medium Induces Tumoricidal Effects on Lymphoma Cells Through Hydrogen Peroxide Mediation.
Lin HD; Fong CY; Biswas A; Choolani M; Bongso A
J Cell Biochem; 2016 Sep; 117(9):2045-55. PubMed ID: 27392313
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms.
Shohara R; Yamamoto A; Takikawa S; Iwase A; Hibi H; Kikkawa F; Ueda M
Cytotherapy; 2012 Nov; 14(10):1171-81. PubMed ID: 22900957
[TBL] [Abstract][Full Text] [Related]
13. Human keloid cell characterization and inhibition of growth with human Wharton's jelly stem cell extracts.
Fong CY; Biswas A; Subramanian A; Srinivasan A; Choolani M; Bongso A
J Cell Biochem; 2014 May; 115(5):826-38. PubMed ID: 24265231
[TBL] [Abstract][Full Text] [Related]
14. Manufacturing of human Wharton's jelly stem cells for clinical use: selection of serum is important.
Kong CM; Lin HD; Biswas A; Bongso A; Fong CY
Cytotherapy; 2019 Apr; 21(4):483-495. PubMed ID: 30879965
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic Wharton's Jelly Stem Cell Conditioned Medium Induces Immunogenic Cell Death in Lymphoma Cells.
Lin HD; Fong CY; Biswas A; Bongso A
Stem Cells Int; 2020; 2020():4670948. PubMed ID: 32377203
[TBL] [Abstract][Full Text] [Related]
16. The effect of allogenic human Wharton's jelly stem cells seeded onto acellular dermal matrix in healing of rat burn wounds.
Nazempour M; Mehrabani D; Mehdinavaz-Aghdam R; Hashemi SS; Derakhshanfar A; Zare S; Zardosht M; Moayedi J; Vahedi M
J Cosmet Dermatol; 2020 Apr; 19(4):995-1001. PubMed ID: 31556227
[TBL] [Abstract][Full Text] [Related]
17. Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro.
Gauthaman K; Yee FC; Cheyyatraivendran S; Biswas A; Choolani M; Bongso A
J Cell Biochem; 2012 Jun; 113(6):2027-39. PubMed ID: 22275115
[TBL] [Abstract][Full Text] [Related]
18. Human Wharton's Jelly Stem Cell Secretions Inhibit Human Leukemic Cell Line K562
Huwaikem MAH; Kalamegam G; Alrefaei G; Ahmed F; Kadam R; Qadah T; Sait KHW; Pushparaj PN
Front Cell Dev Biol; 2021; 9():614988. PubMed ID: 33869169
[TBL] [Abstract][Full Text] [Related]
19. Induction of Immunogenic Cell Death in Lymphoma Cells by Wharton's Jelly Mesenchymal Stem Cell Conditioned Medium.
Lin DH; Biswas A; Choolani M; Fong CY; Bongso A
Stem Cell Rev Rep; 2017 Dec; 13(6):801-816. PubMed ID: 28918474
[TBL] [Abstract][Full Text] [Related]
20. The Healing Effects of Conditioned Medium Derived from Mesenchymal Stem Cells on Radiation-Induced Skin Wounds in Rats.
Sun J; Zhang Y; Song X; Zhu J; Zhu Q
Cell Transplant; 2019 Jan; 28(1):105-115. PubMed ID: 30350716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
